Company Overview
About Stipple Bio
Stipple Bio is a precision oncology company that emerged from stealth in April 2026 with a $100 million oversubscribed Series A. The round was co-led by RA Capital Management, Andreessen Horowitz Bio+Health, and Nextech, with additional participation from GV and Emerson Collective — a top-tier syndicate that signals strong scientific conviction in the platform.
Business Model & Competitive Advantage
The company's "Pointillist" platform identifies tumor-specific cell surface epitopes for antibody-drug conjugates (ADCs), taking a differentiated approach in one of oncology's most competitive and capital-intensive therapeutic categories. While the ADC field has become crowded following the success of drugs like Enhertu, Stipple's approach focuses on discovering novel epitopes that existing ADCs cannot access, creating a potential source of first-in-class assets.
Competitive Landscape 2025–2026
Stipple's lead asset, STP-100, is targeted to enter clinical studies in 2027. The company's oversubscribed round in the current biotech funding environment is a strong signal of scientific credibility. With backing from investors who collectively represent hundreds of oncology investments, Stipple enters the clinic with a well-resourced balance sheet and strategic relationships across the oncology ecosystem.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Stipple Bio is an established challenger with significant market presence and competitive offerings in BioTech.
Growth Stage
Stipple Bio has achieved $100M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare Stipple Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Stipple Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Stipple Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Stipple Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →